Khuong Chau Quang 4
4 · NextCure, Inc. · Filed Jun 24, 2022
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Khuong Chau Quang
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-23+14,250→ 14,250 totalExercise: $4.77Exp: 2032-06-22→ Common Stock (14,250 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 23, 2023 and the date of the 2023 Annual Meeting of Stockholders.